BIOATLA INC (BCAB) Stock Earnings & Estimates
USA - NASDAQ:BCAB - US09077B1044 - Common Stock
0.6219 USD
-0.07 (-10%)
0.6337 USD
+0.01 (+1.9%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 11M | -100.00% | |||||||||
| EBITDA YoY % growth | -106.94M -12.44% | -128.466M -20.13% | -73.018M 43.16% | -112.2M -53.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -108.14M -12.13% | -129.687M -19.93% | -73.943M 42.98% | -74.726M -1.06% | -80.425M -7.63% | -94.592M -17.61% | -72.544M 23.31% | -78.107M -7.67% | -89.498M -14.58% | -99.993M -11.73% | -106.293M -6.30% | |
| Operating Margin | N/A | N/A | -672.21% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -2.74 0.72% | -2.59 5.47% | -1.44 44.40% | -1.19 17.36% | -1.22 -2.86% | -1.19 2.50% | -0.92 23.08% | -0.98 -6.67% | -1.12 -14.58% | -1.25 -11.82% | -1.33 -5.69% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 -37.55% | -0.31 -3.13% | -0.30 -15.73% | -0.29 9.16% | -0.29 5.62% | -0.29 6.04% |
| Revenue Q2Q % growth | -100.00% | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.652M -65.50% | -19.166M -17.99% | -13.181M 20.95% | -13.214M 20.84% | -13.248M 28.98% | -13.28M 30.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.32 27.27% | -0.34 | 0.02 | 7.04% |
| Q1 2025 Q2Q % growth | -0.26 45.83% | -0.35 | 0.09 | 26.47% |
| Q4 2024 Q2Q % growth | -0.30 46.43% | -0.39 | 0.09 | 22.60% |
| Q3 2024 Q2Q % growth | -0.22 68.57% | -0.37 | 0.15 | 40.09% |
| Q2 2024 Q2Q % growth | -0.44 41.33% | -0.45 | 0.01 | 1.51% |
| Q1 2024 Q2Q % growth | -0.48 17.24% | -0.55 | 0.07 | 13.18% |
| Q4 2023 Q2Q % growth | -0.56 11.11% | -0.81 | 0.25 | 30.72% |
| Q3 2023 Q2Q % growth | -0.70 -1.45% | -0.82 | 0.12 | 14.22% |
| Q2 2023 Q2Q % growth | -0.75 2.60% | -0.65 | -0.10 | -14.89% |
| Q1 2023 Q2Q % growth | -0.58 10.77% | -0.64 | 0.06 | 9.45% |
| Q4 2022 Q2Q % growth | -0.63 -1.61% | -0.71 | 0.08 | 11.44% |
| Q3 2022 Q2Q % growth | -0.69 -1.47% | -0.82 | 0.13 | 15.49% |
| Q2 2022 Q2Q % growth | -0.77 14.44% | -0.70 | -0.07 | -10.10% |
| Q1 2022 Q2Q % growth | -0.65 -16.07% | -0.68 | 0.03 | 4.86% |
| Q4 2021 Q2Q % growth | -0.62 58.67% | -0.64 | 0.02 | 3.15% |
| Q3 2021 Q2Q % growth | -0.68 | -0.66 | -0.02 | -3.58% |
| Q2 2021 Q2Q % growth | -0.90 | -0.60 | -0.30 | -50.88% |
| Q1 2021 Q2Q % growth | -0.56 | -0.53 | -0.03 | -4.98% |
| Q4 2020 Q2Q % growth | -1.50 | -0.79 | -0.71 | -88.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 1.53M | -1.53M | -100.00% | |
| Q3 2022 Q2Q % growth | 476.003K | -476.003K | -100.00% | |
| Q2 2022 Q2Q % growth | -100.00% | 408K | -408K | -100.00% |
| Q1 2022 Q2Q % growth | 382.5K | -382.5K | -100.00% | |
| Q4 2021 Q2Q % growth | 4.692M | -4.692M | -100.00% | |
| Q3 2021 Q2Q % growth | -100.00% | 11.22M | -11.22M | -100.00% |
| Q2 2021 Q2Q % growth | 250K 31.58% | 250K | % | |
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | 150K -95.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 9.38% | -4.17% |
| Revenue | N/A | N/A | N/A | N/A |